SCHEMBL28779159

SCHEMBL28779159

COCCC(c1ccc(C(C)NC(=O)C(F)(F)F)cc1)N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ACACB O00763 7/20 0.40
▸ IDH1 O75874 3/20 0.40
▸ IDH2 P48735 3/20 0.40
▸ CNR1 P21554 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PTGER4 P35408 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP3A5 P20815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20289382 1.00 MAPT (0.42) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL21799063 0.88 ACACB (0.43) ACACBIDH1IDH2CNR1
SCHEMBL21799062 0.88 ACACB (0.43) ACACBIDH1IDH2CNR1
SCHEMBL21378569 0.88 MAPT (0.45) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL20289586 0.88 MAPT (0.45) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL19700725 0.88 MAPT (0.45) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL20289632 0.87 MAPT (0.44) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL31452023 0.87 MAPT (0.41) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL20289383 0.87 SMN1; SMN2 (0.46) MAPTALDH1A1NPC1MAPK1HTT
SCHEMBL31452104 0.85 MAPT (0.40) MAPTALDH1A1NPC1MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109075-A Mutant IDH1 and IDH2 inhibitors 伊莱利利公司 2022-09-27 — — CN disclosed
CN-110072867-B 7-phenylethylamino-4H-pyrimido [4,5-D ] [1,3] oxazin-2-one compounds as inhibitors of mutant IDH1 and IDH2 伊莱利利公司 2022-07-08 — — CN disclosed
Send feedback